- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 vaccines: where we stand and challenges ahead
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-21
DOI
10.1038/s41418-020-00720-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Equitable Distribution of COVID-19 Therapeutics and Vaccines
- (2020) Thomas J. Bollyky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- If a coronavirus vaccine arrives, can the world make enough?
- (2020) Roxanne Khamsi NATURE
- Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees
- (2020) Shibo Jiang NATURE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can a century-old TB vaccine steel the immune system against the new coronavirus?
- (2020) Jop Vrieze SCIENCE
- Vaccine opponents are gaining in Facebook ‘battle for hearts and minds,’ new map shows
- (2020) Meredith Wadman SCIENCE
- Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
- (2020) Nathan D. Grubaugh et al. CELL
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Russia’s fast-track coronavirus vaccine draws outrage over safety
- (2020) Ewen Callaway NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Russia’s approval of a COVID-19 vaccine is less than meets the press release
- (2020) Jon Cohen SCIENCE
- ‘Vaccine nationalism’ threatens global plan to distribute COVID-19 shots fairly
- (2020) Kai Kupferschmidt SCIENCE
- Officials gird for a war on vaccine misinformation
- (2020) Warren Cornwall SCIENCE
- Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
- (2020) Evangelos J. Giamarellos-Bourboulis et al. CELL
- What can we expect from first-generation COVID-19 vaccines?
- (2020) Malik Peiris et al. LANCET
- Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
- (2020) Barnaby E Young et al. LANCET
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- COVID-vaccine results are on the way — and scientists’ concerns are growing
- (2020) Smriti Mallapaty et al. NATURE
- The underdog coronavirus vaccines that the world will need if front runners stumble
- (2020) Ewen Callaway NATURE
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Trained Innate Immunity, Epigenetics, and Covid-19
- (2020) Alberto Mantovani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
- (2020) Chadi M. Saad-Roy et al. SCIENCE
- Leader of U.S. vaccine push says he‘ll quit if politics trumps science
- (2020) Jon Cohen SCIENCE
- First vaccine may stymie hunt for better ones
- (2020) Jon Cohen SCIENCE
- Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020
- (2020) Miranda J. Delahoy et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Changing Age Distribution of the COVID-19 Pandemic — United States, May–August 2020
- (2020) Tegan K. Boehmer et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
- (2020) Srikanth Muppidi et al. LANCET NEUROLOGY
- Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
- (2020) Enrico Brunetta et al. NATURE IMMUNOLOGY
- Fever, aches from Pfizer, Moderna jabs aren’t dangerous but may be intense for some
- (2020) Meredith Wadman SCIENCE
- Vaccine wagers on coronavirus surface protein pay off
- (2020) Jon Cohen SCIENCE
- The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature
- (2020) Lucia Novelli et al. JOURNAL OF AUTOIMMUNITY
- Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium
- (2019) January Weiner et al. Scientific Reports
- Aging, inflammation and cancer
- (2018) Barbara Bottazzi et al. SEMINARS IN IMMUNOLOGY
- Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant
- (2015) Barbara Bottazzi et al. PLoS One
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now